Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Wenxian Wang's publication output changed over time?
ScholarIQpublication output · 2011–2022
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2022.
1
1
1
2
1
1
2
1
20112015201620182019202020212022
What are the most-cited papers on Wenxian Wang?
ScholarIQmost cited works
Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
Kai Zhang, Xiaohua Hong, Zhengbo Song, Yu Xu, Chengcheng Li, Guoqiang Wang, Yuzi Zhang, Xiaochen Zhao, Zhengyi Zhao, Jing Zhao, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Shangli Cai, Feifei Gu, Yue Hu, Chunwei Xu, Wenxian Wang, Zhenkun Lou, Yong Zhang, Li Liu
Clinical Cancer Research. 2020138 Citations
Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors
Zhijie Wang, Jianchun Duan, Guoqiang Wang, Jing Zhao, Jiachen Xu, Jiefei Han, Zhengyi Zhao, Jun Zhao, Bo Zhu, Minglei Zhuo, Jianguo Sun, Hua Bai, Rui Wan, Xin Wang, Kailun Fei, Shuhang Wang, Xiaochen Zhao, Yuzi Zhang, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Yuezong Bai, Hua Dong, Lei Xiong, Yanhua Tian, Di Wang, Chunwei Xu, Wenxian Wang, Junling Li, Xingsheng Hu, Shangli Cai, Jie Wang
Journal of Thoracic Oncology. 201994 CitationsOPEN ACCESS
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR‐TKI resistance
Wenxian Wang, Zhengbo Song, Yiping Zhang
Cancer Medicine. 201691 CitationsOPEN ACCESS
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma
Wenjing Xiao, Nan Du, Taoyuan Huang, Jinan Guo, Xingkui Mo, Tao Yuan, Yong Chen, Ting Ye, C. Xu, Wenxian Wang, Guoqiang Wang, Shangli Cai, Jing Chen
EBioMedicine. 201884 CitationsOPEN ACCESS
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study
Wenxian Wang, C. Xu, Huafei Chen, Jinhao Jia, Liping Wang, Huijing Feng, Hong Wang, Zhengbo Song, Nong Yang, Yongchang Zhang
Lung Cancer. 202173 Citations
Related on ScholarIQ
Cancer Hospital of Chinese Academy of Medical Sciences
Institution
Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
Paper
Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors
Paper
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR‐TKI resistance
Paper
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma
Paper
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study
Paper